Top Markets
#1 Derive Derive +30.46%
#2 Cross Cross +14.21%
#3 Audiera Audiera +13.22%
#4 The Bitcoin Bull The Bitcoin Bull +10.65%
#5 Geodnet Geodnet +9.21%
#6 Gama Token Gama Token +9.19%
#7 Velvet Velvet +8.25%
#8 Biconomy Biconomy +8.17%
#9 Fake World Assets Fake World Assets +8.05%
#10 Palladium Network Palladium Network +7.97%
Coin of the day
Derive Derive
Settings
Language
ENGLISH
Currency
USD
Theme
Hempstract, Inc. Hempstract, Inc.

Hempstract, Inc.

HPST
Rank in Stocks #35792
Operating across the United States, Hempstract, Inc. develops and supplies... Operating across the United States, Hempstract, Inc. develops and supplies products centered around cannabidiol (CBD) and cannabigerol (CBG). Its catalog features CBD in isolate powder form, alongside various distillate oils. The enterprise adopted the Hempstract, Inc. moniker in November 2020, having previously been known as Riverdale Oil and Gas Corporation. This firm maintains its principal office in Warden, Washington.
Share Price
$0.0165
Last synced: 2025-06-18
Market Cap
$3.43M
Change (1 day)
-36.42%
Change (1 year)
0.00%
Country
US
Trade Hempstract, Inc. (HPST)

Category

Healthcare
P/E ratio for Hempstract, Inc. (HPST)
P/E ratio as of 2026 TTM: 0
According to Hempstract, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Hempstract, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 38.29 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.